AP113P
Goat Anti-Human IgG Antibody, Fc, HRP conjugate
Chemicon®, from goat
Synonym(s):
Anti-Human IgG HRP, Goat Anti-Human IgG
Sign Into View Organizational & Contract Pricing
All Photos(1)
About This Item
UNSPSC Code:
12352203
eCl@ss:
32160702
NACRES:
NA.46
Recommended Products
biological source
goat
Quality Level
conjugate
peroxidase conjugate
antibody form
F(ab′)2 fragment of affinity isolated antibody
antibody product type
secondary antibodies
clone
polyclonal
species reactivity
human
manufacturer/tradename
Chemicon®
technique(s)
ELISA: suitable
western blot: suitable
shipped in
wet ice
target post-translational modification
unmodified
General description
Immunoglobulin G (IgG) is the most common antibody isotype found in the human serum. It exists in four isotypes IgG1, IgG2, IgG3, and IgG4. IgG structure is characterized with four polypeptide chains with two identical heavy (H) chains and two identical λ light (L) chains. These chains are inter-linked by disulfide bonds. IgG is produced by the B cells.
Immunogen
Human IgG
Application
Goat Anti-Human IgG Antibody, Fc, HRP conjugate has been used in enzyme linked immunosorbent assay (ELISA)(1:3,000).
It is also suitable for use in:
It is also suitable for use in:
- enzyme immunoassay (EIA) with OPD: 1:5,000-1:100,000
- immunohistochemistry 1:500-1:5,000
- western blot
Biochem/physiol Actions
Immunoglobulin G (IgG) is implicated in antibody-dependent cell-mediated cytotoxicity (ADCC). It aids in the activation of the classical pathway of the complement system. It neutralizes virus particles and toxins. Maternal IgG is transferred to the fetus through the placenta that is crucial for protecting newborns against infectious diseases. Measurement of IgG levels in severe acute respiratory syndrome coronavirus (SARS‐CoV)‐2 infected patients can be used as a potential strategy to assess the severity and prognosis of coronavirus disease 2019 (COVID‐19).
Physical form
Lyophilized. Buffer = 0.01 M Sodium Phosphate, 0.25 M NaCl, pH 7.6 with 15 mg/mL BSA. Contains no preservative.
Legal Information
CHEMICON is a registered trademark of Merck KGaA, Darmstadt, Germany
Disclaimer
Unless otherwise stated in our catalog or other company documentation accompanying the product(s), our products are intended for research use only and are not to be used for any other purpose, which includes but is not limited to, unauthorized commercial uses, in vitro diagnostic uses, ex vivo or in vivo therapeutic uses or any type of consumption or application to humans or animals.
Not finding the right product?
Try our Product Selector Tool.
Storage Class Code
11 - Combustible Solids
WGK
WGK 3
Certificates of Analysis (COA)
Search for Certificates of Analysis (COA) by entering the products Lot/Batch Number. Lot and Batch Numbers can be found on a product’s label following the words ‘Lot’ or ‘Batch’.
Already Own This Product?
Find documentation for the products that you have recently purchased in the Document Library.
Customers Also Viewed
Mengyan Li et al.
The Journal of clinical investigation, 131(23) (2021-10-22)
To delineate the in vivo role of different costimulatory signals in activating and expanding highly functional virus-specific cytotoxic CD8+ T cells, we designed synTacs, infusible biologics that recapitulate antigen-specific T cell activation signals delivered by antigen-presenting cells. We constructed synTacs
Sally Esmail et al.
Cell reports methods, 1(2), 100011-100011 (2021-07-09)
We have developed a rapid, accurate, and cost-effective serologic test for SARS-CoV-2 virus, which caused the COVID-19 pandemic, on the basis of antibody-dependent agglutination of antigen-coated latex particles. When validated using plasma samples that are positive or negative for SARS-CoV-2
PCSK9 prosegment chimera as novel inhibitors of LDLR degradation.
Saavedra, YG; Zhang, J; Seidah, NG
Testing null
Margherita Passariello et al.
Scientific reports, 11(1), 11046-11046 (2021-05-28)
Among the therapies against the pandemic SARS-CoV-2 virus, monoclonal Antibodies (mAbs) targeting the Spike glycoprotein represent good candidates to interfere in the Spike/ACE2 interaction, preventing virus cell entry. Since anti-spike mAbs, used individually, might be unable to block the virus
Tara Bancroft et al.
Cellular immunology, 304-305, 35-43 (2016-05-24)
The recent increase in cases of whooping cough among teenagers in the US suggests that the acellular Bordetella pertussis vaccine (aP) that became standard in the mid 1990s might be relatively less effective than the whole-bacteria formulation (wP) previously used
Our team of scientists has experience in all areas of research including Life Science, Material Science, Chemical Synthesis, Chromatography, Analytical and many others.
Contact Technical Service